Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
Kim Hyong reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Medical Officer Hyong Kim received an equity grant of 52,972 shares of Common Stock in the form of restricted stock units at no cash cost. These units vest in roughly equal thirds on each of the first three anniversaries of the grant date, contingent on continued service. Following this grant, Kim holds 386,105 shares directly, underscoring this as a routine, compensation-related award rather than an open-market purchase.
Head James M reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that its Chief Financial Officer, James M. Head, received a grant of 103,002 restricted stock units of common stock. Each unit represents one share and will vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, contingent on his continued service. Following this award, his direct common stock holdings total 184,595 shares.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported mixed insider activity in Common Stock. On March 13, 2026, she received 161,860 restricted stock units, each representing one share, which will vest in roughly equal thirds on each of the first three anniversaries of the grant date, subject to continued service.
On March 16, 2026, she completed an open-market sale of 30,000 shares at a weighted-average price of $17.4809 per share, with individual sale prices ranging from $17.12 to $17.60. Following the sale, she directly held 1,095,562 shares of Common Stock. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on May 22, 2025.
KAO JOHN E reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Executive Officer John E. Kao received a grant of 338,434 restricted stock units of Common Stock on March 13, 2026. The grant was made at no cash purchase price as a stock-based compensation award.
Each restricted stock unit represents the right to receive one share of Common Stock and will vest approximately one third on each of the first three anniversaries of the grant date, subject to Mr. Kao’s continued service with the company. Following this grant, he holds 1,857,914 shares directly and 2,472,641 shares indirectly through the JEK Trust, of which he is trustee.
Vorhoff Nicholas Robbert reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. disclosed that director Nicholas Robbert Vorhoff was granted 18,982 restricted stock units, each representing one share of common stock. These units vest on the one-year anniversary of the grant date if he continues serving on the Board.
The filing shows 173,408 common shares credited to his direct holdings after the grant. According to the footnote, the RSUs are held solely for the benefit of General Atlantic Service Company, L.P., and Vorhoff disclaims beneficial ownership of both the RSUs and the underlying common stock.
McClellan Mark B. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Mark B. McClellan received an equity award of 13,096 restricted stock units of Common Stock. These units were granted at no cash cost and will vest on the one-year anniversary of the grant date, provided he continues serving on the Board of Directors. After this grant, he holds 370,531 shares directly, reflecting routine, compensation-related equity alignment with shareholders rather than an open-market purchase.
McCarthy Margaret M reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Margaret M. McCarthy reported receiving a grant of 14,273 restricted stock units (RSUs), each representing one share of common stock. All RSUs will vest on the one-year anniversary of the grant date if she continues serving on the Board of Directors. Following this award, she directly holds 144,441 shares. She has elected to defer receipt of the underlying shares until she separates from service as a director or a change of control of the company occurs.
KOSECOFF JACQUELINE B reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Jacqueline B. Kosecoff reported an equity grant of 13,096 shares of Common Stock in the form of restricted stock units. These RSUs were awarded at no cash cost to her as a standard grant, not an open-market purchase.
Each restricted stock unit represents one share of Common Stock and will fully vest on the one-year anniversary of the grant date, assuming she continues to serve on the Board of Directors through that date. Following this grant, she directly holds 303,963 shares, including the new award.
KONOWIECKI JOSEPH S reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Joseph S. Konowiecki received a grant of 24,868 restricted stock units, each representing one share of common stock. These RSUs will fully vest on the first anniversary of the grant date, provided he continues serving on the Board. He has elected to defer receipt of the underlying shares for three years, or earlier upon separation of service or a change of control. Following this award, he holds 1,081,009 shares directly.
JORDEN YON reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare director Jorden Yon received a new equity grant. The filing shows an award of 13,096 restricted stock units of Alignment Healthcare, Inc. common stock, with no cash paid per share. After this grant, Yon directly holds 105,830 shares or share equivalents.
Each of the 13,096 restricted stock units represents a right to receive one share of common stock. The entire grant will vest on the one-year anniversary of the grant date, as long as Yon continues serving on the Board of Directors through that date.